Hence, ALA could emerge as a safe and effective adjunctive anti-diabetic therapy with insulin-sensitizing activity along with angiotensin-converting enzyme inhibitors such as ramipril for prevention and treatment of DCM. Here, INS is linked to familial dilated cardiomyopathy.